Genentech

A Genentech-partnered Vijay Pande favorite nabs $52M to advance an AI pipeline
Endpoints
Wed, 12/2/20 - 10:43 am
Genesis
artificial intelligence
Genentech
Growing Opportunities – The Latest Job Expansions in the Life Sciences Industry
BioSpace
Tue, 12/1/20 - 11:01 am
hirings
Genentech
Revance Therapeutics
Novavax
Cold Chain Technologies
August Bioservices
Halda
FDA approves Roche’s Xofluza to prevent flu spreading in families
Pharmaforum
Tue, 11/24/20 - 10:26 am
FDA
Xofluza
Roche
Genentech
Flu
FDA begins review of Samsung Bioepis/Biogen’s Lucentis biosimilar
Pharmaforum
Thu, 11/19/20 - 10:33 am
Novartis
Genentech
Lucentis
biosimilars
Samsung Bioepis
Biogen
FDA
Roche's James Sabry inks his second AI deal in back-to-back pacts — this time partnering Genentech with Stanford spinout Genesis Therapeutics
Endpoints
Mon, 10/19/20 - 11:07 pm
Roche
Genentech
artificial intelligence
drug development
drug discovery
Genesis Therapeutics
FDA grants full approval for Roche/AbbVie’s Venclexta in AML combination therapies
Pharmaforum
Mon, 10/19/20 - 10:56 am
Roche
Genentech
AbbVie
Venclexta
AML
clinical trials
FDA
Months after retiring from Genentech, Michael Varney brings his drug hunting eye to Frazier
Endpoints
Tue, 10/13/20 - 11:18 am
Michael Varney
Genentech
R&D
Frazier Healthcare
Genentech pays $200M for Vaccibody's phase 1 cancer vaccine
Fierce Biotech
Thu, 10/1/20 - 10:05 am
Genentech
Vaccibody
cancer
vaccines
Roche
cancer vaccines
'Rigged' healthcare? Genentech survey reveals unfair treatment among marginalized groups
Motley Fool
Sun, 09/27/20 - 11:05 pm
Roche
Genentech
racial diversity
racial discrimination
Hits, but mostly misses for Roche’s 4 late-stage trials of GI drug hopeful etrolizumab
Fierce Biotech
Mon, 08/10/20 - 10:53 am
Roche
Genentech
etrolizumab
clinical trials
ulcerative colitis
Genentech to eliminate 474 positions
Beckers Hospital Review
Wed, 07/29/20 - 11:53 pm
Genentech
layoffs
COVID-19
Genentech's Tecentriq-Avastin Combo Fails to Hit Primary Endpoint in Ovarian Cancer
BioSpace
Mon, 07/13/20 - 12:15 pm
Genentech
Roche
clinical trials
Tecentriq
ovarian cancer
I-O blockbusters from Merck, BMS and more linked to poor COVID-19 outcomes: study
Fierce Pharma
Thu, 06/25/20 - 08:36 pm
immuno-oncology
checkpoint inhibitors
Merck
Bristol-Meyers Squibb
COVID-19
Keytruda
Opidvo
Yervoy
Genentech
Tecentriq
AstraZeneca
Imfinzi
Roche's Checkpoint Inhibitor Hits the Mark in Early Triple-Negative Breast Cancer Study
BioSpace
Thu, 06/18/20 - 08:38 pm
Roche
Genentech
Tecentriq
triple negative breast cancer
clinical trials
Celgene
Abraxane
Denali scoots past a setback with barely a scratch, quickly calling up a backup Alzheimer’s player on the bench
Endpoints
Wed, 06/10/20 - 11:00 am
Denali Therapeutics
Genentech
DNL747
Genentech’s Phase III Trial Yields Positive Results and Hope for Patients with Wet AMD
BioSpace
Wed, 05/27/20 - 11:56 pm
Genentech
clinical trials
wet age-related macular degeneration
ranibizumab
Genentech posts long-term data on near-approval Soliris rival
Fierce Biotech
Fri, 05/22/20 - 10:46 am
Genentech
satralizumab
Soliris
Alexion
NMOSD
3 Roche Companies Hope to Make Clinical Trials More Efficient
Medical Devices and Diagnostics Industry
Tue, 05/19/20 - 11:19 pm
Flatiron Health
Foundation Medicine
Genentech
Roche
genomics
clinical trials
lung cancer
FDA approves Genentech’s Tecentriq as first-line monotherapy for certain people with metastatic NSCLC
Pharmaceutical Business Review
Tue, 05/19/20 - 10:44 am
Genentech
Roche
Tecentriq
FDA
metastatic non-small cell lung cancer
Genentech lures Regev from Broad Institute to lead research and early development
Fierce Biotech
Mon, 05/11/20 - 10:31 am
Genentech
Broad Institute
R&D
Aviv Regev

Pages